EC approves Novartis' Jakavi; FDA lifts hold on LPath program;

 @FierceBiotech: Special report: The Alzheimer's pipeline... What's next? Report | Follow @FierceBiotech

 @JohnCFierce: Resverlogix touts positive PhIIb atherosclerosis data, sets sights on PhIII deal. More | Follow @JohnCFierce

 @RyanMFierce: What changes will Roche vet Pascal Soriot make as CEO of AstraZeneca? More | Follow @RyanMFierce

> The European Commission has approved Novartis' ($NVS) Jakavi, a new drug for myelofibrosis licensed from Incyte. Story

> LPath reported that the FDA has lifted the clinical hold on iSONEP, an anti-S1P monoclonal antibody being developed as a potential treatment for wet AMD and possibly other ocular disorders. Release

> Catalyst Pharmaceutical Partners is raising $6 million in a new stock offering designed to fund its drug development work. Story

> Rexahn Pharmaceuticals says it gathered positive data in a Phase II clinical study of Archexin, its clinical-stage pancreatic cancer drug candidate. A penny stock company, Rexahn's shares jumped 22% on the news. Release

Pharma News

 @FiercePharma: AstraZeneca's gain is Roche's loss: Stock down 1% after $AZN woos away Pascal Soriot for CEO job. More | Follow @FiercePharma

> Forest adopts 'poison pill' to fend off Icahn. Report

> AstraZeneca entices Roche exec to take on CEO challenge. News

> Gilead draws early fire for new HIV med's $28K price. Story

Medical Device News

@FierceMedDev: Moving on from the Duet recall, Covidien gets a 510(k) for its next-gen surgical stapler. News | Follow @FierceMedDev

 @MarkHFierce: Stent use can help certain patients more than medical therapy if used on the early side. Release | Follow @MarkHFierce

 @DamianFierce: Joining other big shots in the device game, Medtronic has opened an R&D center in China. Report | Follow @DamianFierce

> Shake-up at Roche puts Diggelmann in charge of diagnostics. News

Biotech Research News

> Acorda's drug treats nerve damage-related ED in preclinical test. Article

> Novira raises $23M for hepatitis B/HIV drug work. News

> Genentech, U. Minnesota scientists discover new colon cancer red flags. Story

> Johns Hopkins team turning blood cells into stem cells. More

> Melanoma stem cells may carry provocative drug target. Item

Pharma Manufacturing News

> Drugmaker EirGen thinks plan to put waste station nearby stinks. More

> Sun says FDA clears plants where Marshalls seized products in 2009. News

> CSL, whose vaccine was tied to convulsions, gets FDA closeout letter. Story

> Hospira commits to 200 jobs, $85M investment, at troubled plant. Report

And Finally… Researchers from the University of Bonn and MPI Martinsried say they have "decoded signals that boost the burning of fat." Release


Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.